Word

AVIDATRO

Status

Dead

Status Code

606

Status Date

Monday, March 14, 2022

Serial Number

88690331

Mark Type

4000

Filing Date

Wednesday, November 13, 2019

Published for Opposition

Tuesday, June 16, 2020

Abandoned Date

Monday, March 14, 2022

Trademark Owner History

Amgen Inc. - Owner At Publication

Classifications

5 pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders

Trademark Events

Mar 14, 2022

Abandonment Notice E-Mailed - No Use Statement Filed

Mar 14, 2022

Abandonment - No Use Statement Filed

Jul 29, 2021

Notice Of Approval Of Extension Request E-Mailed

Jul 27, 2021

Extension 2 Granted

Jul 27, 2021

Extension 2 Filed

Jul 27, 2021

Teas Extension Received

Feb 4, 2021

Notice Of Approval Of Extension Request E-Mailed

Feb 2, 2021

Extension 1 Granted

Feb 2, 2021

Extension 1 Filed

Feb 2, 2021

Teas Extension Received

Aug 11, 2020

Noa E-Mailed - Sou Required From Applicant

Jun 16, 2020

Official Gazette Publication Confirmation E-Mailed

Jun 16, 2020

Published For Opposition

May 27, 2020

Notification Of Notice Of Publication E-Mailed

May 12, 2020

Assigned To Lie

May 8, 2020

Approved For Pub - Principal Register

May 8, 2020

Teas/Email Correspondence Entered

May 8, 2020

Correspondence Received In Law Office

May 8, 2020

Teas Response To Office Action Received

Dec 27, 2019

Notification Of Non-Final Action E-Mailed

Dec 27, 2019

Non-Final Action E-Mailed

Dec 27, 2019

Non-Final Action Written

Dec 26, 2019

Assigned To Examiner

Nov 19, 2019

New Application Office Supplied Data Entered In Tram

Nov 16, 2019

New Application Entered In Tram